PMID: 15227080Jun 1, 1984Paper

Amiodarone pulmonary toxicity

Texas Heart Institute Journal
G Liss, R D Leachman

Abstract

Amiodarone therapy for the treatment of arrhythmias has been found to have severe side effects. Although the drug has been prescribed in Europe for more than 20 years, it has only recently been used in the United States as an investigational drug, and has been found to cause pulmonary toxicity, as well as other major side effects. In the following report, a case of pulmonary toxicity caused by Amiodarone was resolved by steroid therapy. A review of the literature suggests that physicians prescribing this medication should be alert to the possibility of pulmonary toxicity.

Citations

Dec 11, 1991·Biochemical Pharmacology·J M Antonini, M J Reasor
Jun 17, 1996·Toxicology·P G ReinhartC G Gairola
Apr 1, 1991·Toxicology Letters·R J RuchJ E Klaunig

❮ Previous
Next ❯

Related Feeds

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Antiarrhythmic Agents: Mechanisms of Action

Understanding the mechanism of action of antiarrhythmic agents is essential in developing new medications as treatment of cardiac arrhythmias is currently limited by the reduced availability of safe and effective drugs. Discover the latest research on Antiarrhythmic Agents: Mechanism of Action here.